By 2060, an estimated 48 million people each year will die with serious health-related suffering, representing an 87% increase from 2016.
Patients with serious illnesses experience a significant burden of suffering, and research has shown that palliative care can relieve suffering for patients and families, as well as save money for health systems. However, 45% of countries have no access to palliative care. In fact, the global burden of serious health-related suffering is expected to nearly double in the next 4 decades, according to a new study.
Published in The Lancet Global Health, the study found that by 2060, an estimated 48 million people annually will die with serious health-related suffering, representing an 87% increase from 2016. With this increased prevalence, serious health-related suffering will account for 47% of all deaths in 2060, up from 45% in 2016.
“Palliative care and the relief of suffering have been described as one of the most neglected dimensions of global health,” wrote the researchers. “In 2018, the Lancet Commission on Palliative Care and Pain Relief stated that no other important health intervention is as lacking or inequitably distributed as pain relief, the pillar of palliative care.”
Conditions expected to drive the increased prevalence include cancer, cerebrovascular disease, lung disease, and dementia. While cancer deaths will account for the most serious health-related suffering in all regions, dementia will have the most rapid increase by 2060, for which the need for palliative care is expected to increase 4-fold.
While countries of all incomes are expected to experience and increase, the overwhelming majority (83%) of these deaths will occur in low- and middle-income countries. Low-income countries will also experience the largest increase during the time period (155%). Meanwhile, lower-middle—income countries will experience an 87% increase and upper-middle–income countries will experience an 88% increase.
High-income countries will experience a 57% increase, representing 3 million more people dying from serious health-related suffering.
These increases in serious health-related suffering will occur most rapidly among older people, with more than 22 million people aged 70 years and older experiencing suffering (183% increase).
Notably, suffering is expected to decrease among younger age groups, ranging from 0 to 49 years, except in low-income countries, which will experience a 5% increase in suffering among children aged 5 to 14 years and among those aged 30 to 49 years.
“Our findings call for global policies to strengthen healthcare systems through availability of essential drugs to relieve symptoms, staff training, and public education, with a focus on the populations that will experience the fastest rise of suffering and need,” said Katherine Sleeman, MBc, MBBS, MRCP, PhD, NHIR clinician scientist and honorary consultant in palliative medicine at the Cicely Saunders Institute at King’s College London and lead author of the study, in a statement.
Reference:
Sleeman K, Brito M, Etkind S, et al. The escalating global burden of serious health-related suffering: projections to 2060 by world regions, age groups, and health conditions [published online May 22, 2019]. Lancet Glob Health. doi: 10.1016/S2214-109X(19)30172-X.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More
2 Commerce Drive
Cranbury, NJ 08512